Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of East Anglia Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Glasgow Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
University College London Featured PhD Programmes
"melanoma"×
10 miles

melanoma PhD Projects, Programs & Scholarships

We have 18 melanoma PhD Projects, Programs & Scholarships

  • "melanoma" ×
  • clear all
Order by 
Showing 1 to 10 of 18
  MRC DiMeN Doctoral Training Partnership: Understanding the genetics of melanoma by studying heritable risk factors
  Dr MM Iles, Prof T Bishop
Application Deadline: 21 January 2019
Background. Melanoma is the fifth most common cancer in the UK and its incidence has risen faster than any other common cancer - a five-fold increase since 1975.
  The role of tumour microenvironment interactions in melanoma therapy resistance
  Research Group: Institute of Cancer Therapeutics
  Dr H Sheldrake, Dr M Sutherland
Applications accepted all year round
The incidence of malignant melanoma has steadily increased over the past 30 years, and it is predicted that 76,250 new cases will be diagnosed in the US and over 10,000 in the UK this year.
  Exploiting a new therapeutic target in malignant melanoma (MORRISCU19SF)
  Dr C Morris
Application Deadline: 31 May 2019
BACKGROUND. Despite recent advancements in treatment, cutaneous melanoma still remains a deadly disease once it has metastasised.
  The role of isothiocyanates-derived from natural sources in uveal melanoma chemoprevention (ref: SF18/APP/McDermott)
  Prof A McDermott, Prof M Panagiotidis, Dr G Koutsidis
Applications accepted all year round
Uveal melanoma is the most frequent primary intraocular tumor, in Caucasian adults, and one that is very difficult to treat once it becomes metastatic.
  DNA Strategic Epigenetic Biomarkers in Melanoma
  Dr C Proby, Prof C N A Palmer
Applications accepted all year round
Hypothesis. That tumour-specific DNA methylation present in free circulating DNA from melanoma patients will enable early detection of disease relapse or metastasis facilitating life-preserving benefit from additional therapies such as immune checkpoint inhibitors.
  MRC DiMeN Doctoral Training Partnership: Harnessing T cells to target brain metastases
  Dr M Lorger, Dr R Salmond, Prof J Newton-Bishop
Application Deadline: 21 January 2019
An MRC-funded PhD student position is available to explore how T cells can be harnessed to enhance the efficacy of immune checkpoint inhibitors in melanoma brain metastases.
  Impact of targeted therapy on the melanoma immune microenvironment
  Dr K. Sheppard, Prof G. McArthur
Applications accepted all year round
The treatment of melanoma is undergoing a fundamental change due to the success of both targeted therapies directed at the MAPK/ERK pathway and immunotherapies.
  Quantitative proteomic and cell biological analysis of TGF driven tumour promotion in melanoma and squamous cell cancers
  Dr G J Inman, Prof A I Lamond
Applications accepted all year round
Transforming growth factor- can act as both a potent tumour suppressor and tumour promoter in a context dependent manner.
  ALDH function in the melanoma
  Research Group: MRC Human Genetics Unit
  Dr E Patton
Application Deadline: 18 January 2019
This is one of several projects available on an MRC funded 4-year multi-disciplinary PhD programme in Human Genetics, Genomics and Disease at the MRC Human Genetics Unit (HGU), part of the Institute of Genetics and Molecular Medicine (IGMM) at the University of Edinburgh.
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard, Prof G. McArthur
Applications accepted all year round
Targeted therapy has had profound impact on outcomes for cancer patients.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.